home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search
 
 

Monoclonal Antibodies and Fraction of Antibodies in Biopharmaceuticals: An Introduction

  
  April 11, 2019
Pharma Development and Business
  
     
 
CfPA-The Center for Professional Advancement, Online Live
June 19, 2019 at 11:00 a.m.–12:30 p.m. (ET)

Who Should Attend?
This online training will be most useful for people working in or interested in the Biopharmaceutical industry who need a solid grasp of monoclonal antibody (Mab) and/or fractions of antibodies (Fab). This course will benefit people in quality control, quality assurance, analytics and research departments by giving them a solid grasp on the basics of monoclonal antibodies and fraction of antibodies.

Course Description
This course will benefit the personnel who are responsible for quality or analytics of Mab’s and Fab’s. This 90-minute accredited course will include discussions on the basic properties of Mab’s and Fab’s as well as their history in the pharmaceutical industry. The course will also include a basic set of analysis used for Mab and Fab to determine quality. The course will also discuss different quality attributes that can affect a Mab or Fab. 

Can't Make this LIVE Webinar? 
Simply select the On Demand option when registering and we will send you the link to view the recorded version.

On Demand available approximately 3 business days after the live offering.

 

  
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Rachel Monsef, Consultant to the biopharmaceutical and pharmaceutical industries

Rachel Monsef is a consultant to the biopharmaceutical and pharmaceutical industry for analytical and quality control. She has 19 years’ experience working with many types of assays for all stages of drug development. She has been responsible for method development, method qualification, method validation, assay transfers, characterization work and stability studies. Ms. Monsef also worked with manufacturing groups to develop and perform assays to support their efforts. She has previously worked for Seattle Genetics and Alder Biopharmaceuticals and is currently consulting for both companies.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.